Abiopharma

Myers Colleen Elizabeth 🟡 adjusted position in 201 shares (3 derivative) of VISTEON CORP (VC) at $89.09 Transaction Date: Mar 15, 2026 | Filing ID: 000008

Ribeiro Joao Paulo 🟡 adjusted position in 768 shares (3 derivative) of VISTEON CORP (VC) at $90.06 Transaction Date: Mar 15, 2026 | Filing ID: 000007

New Form 3 - Empire State Realty Trust, Inc. <b>Filed:</b> 2026-03-17 <b>AccNo:</b> 0002118467-26-000002 <b>Size:</b> 486 KB

Director Lauder William P 🟢 acquired 3 shares (1 derivative) of ESTEE LAUDER COMPANIES INC (EL) Transaction Date: Mar 16, 2026 | Filing ID: 000002

PYNNONEN BRETT D 🟡 adjusted position in 1.3K shares (3 derivative) of VISTEON CORP (VC) at $90.06 Transaction Date: Mar 15, 2026 | Filing ID: 000008

Director Long Annabelle Yu 🟢 acquired 3 shares (1 derivative) of ESTEE LAUDER COMPANIES INC (EL) Transaction Date: Mar 16, 2026 | Filing ID: 000002

Coler Thomas 🟡 adjusted position in 2.3K shares (4 derivative) of QUAKER CHEMICAL CORP (KWR) at $118.45 Transaction Date: Mar 15, 2026 | Filing ID: 000002

Kim Seungkyung 🟡 adjusted position in 401 shares (3 derivative) of VISTEON CORP (VC) at $90.06 Transaction Date: Mar 15, 2026 | Filing ID: 000008

Director Zinterhofer Eric Louis 🟢 acquired 17 shares (2 derivative) of ESTEE LAUDER COMPANIES INC (EL) Transaction Date: Mar 16, 2026 | Filing ID: 000004

Sharif Qais M 🟡 adjusted position in 852 shares (3 derivative) of VISTEON CORP (VC) at $90.06 Transaction Date: Mar 15, 2026 | Filing ID: 000007